Improvement of scleromyxedema associated with isotretinoin therapy.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 2050852.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The treatment of scleromyxedema has been largely ineffective. We report improvement of scleromyxedema with myopathy after treatment with isotretinoin, 40 mg twice a day. We review other therapeutic modalities used for this disorder and discuss properties of isotretinoin that may have contributed to the favorable response.
Medical subject headings
- Isotretinoin
- Myxedema
- Skin Diseases